Inflammatory Bowel Disease (IBD) is a chronic inflammatory condition that affects the digestive tract and includes conditions such as Crohn's disease and ulcerative colitis. IBD is characterized by inflammation that can lead to damage and scarring of the intestinal tissue. The symptoms of IBD can be severe and include abdominal pain, diarrhea, fatigue, weight loss, and malnutrition. IBD is typically diagnosed through a combination of clinical evaluation, blood tests, and imaging studies.
Studies have found that patients with Inflammatory Bowel Disease (IBD) have an altered oral microbiome compared to healthy individuals. Specifically, there is a higher prevalence of certain bacteria, such as Fusobacterium nucleatum, in the oral microbiome of patients with IBD. This suggests that the oral microbiome may contribute to the development and progression of IBD.
One theory is that the disruption of the oral microbiome can lead to an overgrowth of harmful bacteria in the gut, which can contribute to the development of IBD symptoms. Additionally, the inflammation caused by oral bacteria in the mouth may spread to the gut and worsen inflammation in individuals with IBD.
Fusobacterium nucleatum is a Gram-negative anaerobic bacterium that is commonly found in the human oral cavity and gastrointestinal tract. It is a pathogenic bacterium associated with various oral and systemic diseases, including periodontal disease, colorectal cancer, and intra-abdominal infections.
Fusobacterium nucleatum is known for its ability to adhere to and invade host cells, which contributes to its pathogenicity. It can also form biofilms, which are complex communities of bacteria that are attached to surfaces and can be difficult to remove. F. nucleatum is considered a "bridge organism" that can facilitate the colonization and growth of other pathogenic bacteria in the oral cavity, contributing to the development of periodontal disease.
Several studies have suggested a potential association between Fusobacterium nucleatum and IBD. F. nucleatum has been found in higher abundance in the gut microbiota of patients with IBD compared to healthy individuals. It has been shown to have pro-inflammatory properties and can stimulate the production of inflammatory cytokines, which are molecules involved in the immune response, leading to increased inflammation in the gut.
F. nucleatum has also been found to interact with other gut bacteria and host cells in a way that may contribute to the development or progression of IBD. For example, F. nucleatum has been shown to adhere to and invade intestinal epithelial cells, disrupting the gut barrier function and promoting inflammation. It has also been found to interact with immune cells in the gut, potentially modulating the immune response and contributing to the chronic inflammation seen in IBD.
The treatment of IBD typically involves a combination of lifestyle changes, dietary modifications, and medication. The goal of treatment is to manage symptoms and improve quality of life for the patient.
Lifestyle changes may include stress reduction techniques, regular exercise, and getting enough sleep. A registered dietitian can help develop a personalized nutrition plan for patients with IBD. In severe cases of IBD, surgery may be necessary to remove damaged or inflamed sections of the digestive tract.
Additionally, poor oral hygiene and gum disease have been linked to an increased risk of developing IBD. Maintaining good oral hygiene and a healthy oral microbiome is essential for reducing the risk of developing IBS and other gastrointestinal disorders. By keeping the oral microbiome in balance and reducing harmful bacteria in the mouth, individuals may be able to reduce the risk of gut dysbiosis and inflammation.
At Dentulu, we offer a variety of services and treatments to help our patients maintain good oral hygiene, including regular dental check-ups, cleanings, and salivary testing for the oral microbiome. By taking a proactive approach to oral health, we can help our patients maintain overall health and wellbeing.
Generally, a salivary testing report will include the patient's identifying factors such as age, name, gender, and the date of the test. Next it will identify the testing results which could include inflammatory markers, oxidative stress markers, and genetic markers. Finally it will include a section on interpreting your results.
At Dentulu, we highly recommend each patient to schedule an appointment with their general dentist or primary care physician, or one of our highly trained Dentulu Teledentists who can discuss with you and assess your current dental and health conditions as well as prior health history to come up with the most appropriate care plan for your needs.
See Sample Report
It’s simple! Click the link below, choose the package you'd like, follow the prompts, and have the kit delivered right to your door!
Once your test results come in, you can interpret the results yourself, follow up with your regular dentist, or schedule a consultation with one of our Dentulu Teledentists from your computer or mobile device at any time that is convenient for you!
Interpreting Your Test Results
Provider Subscription
Dental Patients
Vendors
